muscarinic acetylcholine receptor

The muscarinic acetylcholine receptor (mAChR) is a type of receptor found throughout the brain and body that responds to the neurotransmitter acetylcholine. Unlike its counterpart, the nicotinic acetylcholine receptor, it is metabotropic — meaning it works through a chain of intracellular signals rather than directly opening an ion channel.

Five subtypes exist, labelled M1 through M5. They are distributed widely: in the cortex and hippocampus, in smooth muscle and glandular tissue, and in the heart. This broad distribution explains why substances that block these receptors produce such a wide range of effects across the body and mind.

The receptors are named for muscarine, a compound found in certain toxic mushrooms, which activates them selectively.

How it works · its role

Under normal conditions, acetylcholine released at a synapse binds mAChRs and activates coupled G-proteins, which then modulate intracellular signalling cascades. The specific effect depends on the subtype: M1 receptors are associated with cortical arousal and memory encoding; M2 receptors slow the heart and act as inhibitory autoreceptors; M3 receptors govern secretions from glands and contraction of smooth muscle.

When a substance blocks these receptors — acting as an antagonist — acetylcholine can no longer bind, and the normal downstream signals are suppressed. This produces the classic anticholinergic profile: reduced secretions, altered heart rate, smooth-muscle relaxation, and, in the brain, pronounced changes in cognition and perception.

Relevance to substances & effects

Muscarinic antagonism is the defining mechanism of the deliriant class of psychoactive substances. Tropane alkaloids such as atropine, scopolamine, and hyoscine — found in plants like datura, Brugmansia, and henbane — bind mAChRs with high affinity, producing dry mouth, blurred vision, urinary retention, elevated heart rate, and, at higher doses, a confused, amnesic delirium that is generally considered unpleasant and difficult to navigate.

Diphenhydramine, a common antihistamine, also carries significant muscarinic antagonism, which accounts for its sedative and, in overdose, deliriant properties.

Beyond dedicated deliriants, many tricyclic antidepressants and older antipsychotics have notable mAChR antagonism as a side-effect profile, contributing to cognitive blunting, constipation, and dry mouth with regular use.

On the agonist side, the alkaloid muscarine itself activates these receptors and serves as a research tool, though it is not used as a psychoactive substance in practice.

Clinical · risk note

Anticholinergic toxidrome is the clinical emergency that follows significant mAChR blockade. The signs are often summarised as: dry and flushed skin, elevated heart rate, urinary retention, dilated pupils, and a hot, confused mental state. In severe cases — particularly with Datura or large diphenhydramine doses — seizures and dangerous hyperthermia can follow.

Because delirium can be total and amnesia is common, people under the influence may not recognise their own condition or seek help. Physostigmine, a cholinesterase inhibitor, is used in clinical settings to reverse the syndrome by raising available acetylcholine. Any suspected significant anticholinergic overdose warrants emergency medical attention.